T3 Tablets

Overview

T3 Tablets British Dragon deliver synthetic triiodothyronine (liothyronine) at a precise 25 mcg per tablet, supplied in 100-tab packs for a total of 2,500 mcg per unit. Unlike anabolic steroids, T3 is a thyroid hormone — it does not act on androgen receptors but instead binds thyroid hormone receptors in virtually every cell of the body, directly accelerating basal metabolic rate, thermogenesis, and nutrient oxidation. In bodybuilding and physique sport contexts it is used during cutting phases to amplify the caloric-deficit effect, drive fat oxidation beyond what diet alone achieves, and counter the metabolic slowdown that occurs during extended caloric restriction. steroidwarehouse.com carries the British Dragon T3 formulation alongside Dragon Pharma T3 and T4 for users comparing options within the thyroid hormone category.

About the Compound

Liothyronine is the biologically active form of thyroid hormone — the same molecule produced endogenously when thyroxine (T4) is converted to T3 by deiodinase enzymes in peripheral tissue. Exogenous T3 bypasses that conversion step, producing a faster and more predictable elevation of intracellular thyroid receptor activity than supplemental T4. This pharmacokinetic characteristic — shorter half-life, faster onset, more direct action — makes liothyronine the preferred thyroid compound for performance contexts where the goal is a defined, time-limited metabolic acceleration.

At the cellular level, T3 binds thyroid hormone receptors (predominantly TRα in cardiac and skeletal muscle, TRβ in liver and fat tissue) and upregulates genes responsible for oxidative metabolism, thermogenesis, and protein turnover. The consequence is increased caloric expenditure, enhanced fat substrate utilization, and — at high doses or without protein and anabolic support — accelerated lean tissue catabolism. Managing this catabolic risk through adequate dietary protein and concurrent anabolic compounds is the central protocol consideration when using T3 in a cutting cycle.

What It Does

• Raises basal metabolic rate (BMR): T3 directly upregulates mitochondrial uncoupling and oxidative phosphorylation across multiple tissue types. At 50–75 mcg/day, BMR elevation of 10–20% above baseline is a commonly reported functional outcome, translating to several hundred additional calories burned daily without changes to activity level or diet composition.
• Accelerates fat oxidation: Elevated T3 increases lipolysis signaling and shifts substrate utilization toward fat oxidation. In a caloric deficit this amplifies the rate of fat loss beyond what the deficit alone produces. The effect is particularly pronounced in subcutaneous and visceral fat stores, making T3 useful in the final weeks of a pre-contest cut.
• Counters metabolic adaptation: Prolonged caloric restriction suppresses endogenous T3 production as a homeostatic response, reducing BMR and blunting fat loss progress over time. Exogenous T3 supplementation offsets this adaptive down-regulation, maintaining a more consistent rate of fat loss across the full cut duration.
• Increases protein turnover: T3 accelerates both protein synthesis and protein breakdown simultaneously. At doses above 50 mcg/day, the net effect on lean tissue becomes catabolic without adequate protein intake (>2.2 g/kg/day) and anabolic hormone support. This is why T3 is almost always run alongside AAS or other anabolic compounds in physique protocols.
• Thermogenic output: Thyroid hormone receptor activation in brown adipose tissue and skeletal muscle increases heat production. This thermogenic effect contributes to the elevated sweating and body temperature that users notice within the first week of T3 use, and it represents a meaningful additional source of caloric expenditure on top of the BMR elevation.
• Synergy with lipolytic compounds: T3 potentiates the fat-loss effect of beta-2 agonists (clenbuterol, salbutamol) by upregulating beta-adrenergic receptor sensitivity. When combined, the two compounds produce greater fat oxidation than either does alone, which is the basis of the classic T3 + clenbuterol cutting stack.

Who It's For

T3 Tablets BD are suited to intermediate-to-advanced users in defined cutting phases who have plateaued on diet and cardio alone, or who are managing the metabolic slowdown that accumulates over 10–16 week contest prep cycles. The core differentiator from other metabolic compounds is mechanism: T3 accelerates energy expenditure at the cellular level across the entire body, not just in adrenergic tissue. This makes its fat-loss contribution additive regardless of what other compounds are in the stack.

Compared to Clenbuterol Tablets BD, T3 operates through a completely different pathway — thyroid receptor agonism rather than beta-2 adrenergic stimulation. Clenbuterol provides acute thermogenesis with receptor desensitization at 2–3 weeks; T3 produces a sustained metabolic elevation for the full 4–8 week cycle without receptor downregulation. The two mechanisms are complementary, making T3 + clenbuterol one of the most frequently used cutting combinations. T3 is the better primary choice when the goal is sustained metabolic rate elevation across a long cut, while clenbuterol is more appropriate for a shorter, sharper thermogenic push.

Users who should not use T3: anyone with pre-existing thyroid disease, cardiac arrhythmia, or uncontrolled hypertension. T3 also requires a meaningful anabolic backbone — users who cannot support the cycle with adequate dietary protein and at minimum a testosterone or other anabolic compound should choose a non-catabolic fat-loss approach instead. Beginners without prior cutting cycle experience are better served by optimizing diet and cardio before introducing thyroid hormones.

T3 vs Alternatives

Combinations

Side Effects & Management

Bloodwork Monitoring

Tapering & Thyroid Recovery

T3 does not suppress the HPG axis and does not require post-cycle therapy in the AAS sense. However, exogenous liothyronine does suppress TSH and the hypothalamic-pituitary-thyroid (HPT) axis during the cycle, and abrupt discontinuation can produce transient rebound hypothyroidism — a state where endogenous T3/T4 production is slower to restart than the exogenous source was removed. The practical consequence is fatigue, cold sensitivity, water retention, and slowed metabolism in the first 1–3 weeks off T3 if the exit is not managed correctly.

Entry taper (ramp up): Start at 25 mcg/day. After 5–7 days at 25 mcg with no adverse cardiac response, increase to 50 mcg/day. If targeting 75 mcg/day, hold at 50 mcg for a further 5–7 days before adding the final increment. Never start at 75 mcg cold.

Exit taper (ramp down): Reverse the titration — reduce by 25 mcg every 3–5 days. A user at 75 mcg/day exits via 75 → 50 → 25 → 0 over approximately 10–15 days. Do not attempt to cut from 75 mcg directly to zero. The slower the exit, the more smoothly endogenous thyroid function restores.

Recovery window: TSH typically returns to the normal range within 4–6 weeks of completing the exit taper. Retest at week 4 post-taper. If TSH remains suppressed beyond 8 weeks, a longer off-period is required before the next T3 cycle. Minimum recommended off-time between T3 cycles: 8–12 weeks to allow full HPT axis normalization.

Practical Summary

T3 Tablets British Dragon provides a reliable oral liothyronine dose for athletes integrating thyroid hormone into cutting phases. At 25 mcg per tablet the dose is fully titrable from the starting point through the 50–75 mcg/day working range without tablet splitting. Used within the 4–8 week window, paired with adequate protein and anabolic support, T3 accelerates the caloric-deficit effect and thermogenic output that cutting cycles target. Steroid Warehouse carries the British Dragon formulation alongside Dragon Pharma T3 and T4 options for users comparing sources and brands within the thyroid hormone category.

References